BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1904870)

  • 21. Identification of amino acid residues responsible for the changes of absorption and fluorescence spectra on the binding of subtilisin BPN' and Streptomyces subtilisin inhibitor.
    Masuda-Momma K; Shimakawa T; Inouye K; Hiromi K; Kojima S; Kumagai I; Miura K; Tonomura B
    J Biochem; 1993 Dec; 114(6):906-11. PubMed ID: 8138550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The complete amino acid substitutions at position 131 that are positively involved in cold adaptation of subtilisin BPN'.
    Taguchi S; Komada S; Momose H
    Appl Environ Microbiol; 2000 Apr; 66(4):1410-5. PubMed ID: 10742220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variants of subtilisin BPN' with altered specificity profiles.
    Rheinnecker M; Eder J; Pandey PS; Fersht AR
    Biochemistry; 1994 Jan; 33(1):221-5. PubMed ID: 8286344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissecting the catalytic triad of a serine protease.
    Carter P; Wells JA
    Nature; 1988 Apr; 332(6164):564-8. PubMed ID: 3282170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetic specificities of BPN' and Carlsberg subtilisins. Mapping the aromatic binding site.
    Karasaki Y; Ohno M
    J Biochem; 1978 Sep; 84(3):531-8. PubMed ID: 102640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of cutinase serine 42 side chain to the stabilization of the oxyanion transition state.
    Nicolas A; Egmond M; Verrips CT; de Vlieg J; Longhi S; Cambillau C; Martinez C
    Biochemistry; 1996 Jan; 35(2):398-410. PubMed ID: 8555209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineering subtilisin BPN' for site-specific proteolysis.
    Carter P; Nilsson B; Burnier JP; Burdick D; Wells JA
    Proteins; 1989; 6(3):240-8. PubMed ID: 2516317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineering the independent folding of the subtilisin BPN' prodomain: analysis of two-state folding versus protein stability.
    Ruvinov S; Wang L; Ruan B; Almog O; Gilliland GL; Eisenstein E; Bryan PN
    Biochemistry; 1997 Aug; 36(34):10414-21. PubMed ID: 9265621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding, proteolytic, and crystallographic analyses of mutations at the protease-inhibitor interface of the subtilisin BPN'/chymotrypsin inhibitor 2 complex.
    Radisky ES; Kwan G; Karen Lu CJ; Koshland DE
    Biochemistry; 2004 Nov; 43(43):13648-56. PubMed ID: 15504027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transition state stabilization by chloramphenicol acetyltransferase. Role of a water molecule bound to threonine 174.
    Lewendon A; Shaw WV
    J Biol Chem; 1993 Oct; 268(28):20997-1001. PubMed ID: 8407936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel engineered subtilisin BPN' lacking a low-barrier hydrogen bond in the catalytic triad.
    Stratton JR; Pelton JG; Kirsch JF
    Biochemistry; 2001 Sep; 40(35):10411-6. PubMed ID: 11523982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for transition-state stabilization by serine-148 in the catalytic mechanism of chloramphenicol acetyltransferase.
    Lewendon A; Murray IA; Shaw WV; Gibbs MR; Leslie AG
    Biochemistry; 1990 Feb; 29(8):2075-80. PubMed ID: 2109633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the amino acid sequence of the serine protease of the fish pathogen Aeromonas salmonicida subsp. salmonicida with those of other subtilisin-type enzymes relative to their substrate-binding sites.
    Coleman G; Whitby PW
    J Gen Microbiol; 1993 Feb; 139(2):245-9. PubMed ID: 8436946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineering thermostability in subtilisin BPN' by in vitro mutagenesis.
    Rollence ML; Filpula D; Pantoliano MW; Bryan PN
    Crit Rev Biotechnol; 1988; 8(3):217-24. PubMed ID: 3145814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probing enzymic transition state hydrophobicities.
    Wangikar PP; Rich JO; Clark DS; Dordick JS
    Biochemistry; 1995 Sep; 34(38):12302-10. PubMed ID: 7547973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do enzymes change the nature of transition states? Mapping the transition state for general acid-base catalysis of a serine protease.
    Bott RR; Chan G; Domingo B; Ganshaw G; Hsia CY; Knapp M; Murray CJ
    Biochemistry; 2003 Sep; 42(36):10545-53. PubMed ID: 12962477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subtilisin Sendai from alkalophilic Bacillus sp.: molecular and enzymatic properties of the enzyme and molecular cloning and characterization of the gene, aprS.
    Yamagata Y; Isshiki K; Ichishima E
    Enzyme Microb Technol; 1995 Jul; 17(7):653-63. PubMed ID: 7605625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Details of the acyl-enzyme intermediate and the oxyanion hole in serine protease catalysis.
    Whiting AK; Peticolas WL
    Biochemistry; 1994 Jan; 33(2):552-61. PubMed ID: 8286385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of subtilisin BPN' by reaction site P1 mutants of Streptomyces subtilisin inhibitor.
    Kojima S; Nishiyama Y; Kumagai I; Miura K
    J Biochem; 1991 Mar; 109(3):377-82. PubMed ID: 1908859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a novel peptide inhibitor of subtilisin BPN'.
    Ishida K; Shimizu M; Wakasugi A; Matsui Y; Nakamura A; Kojima S
    FEBS Open Bio; 2022 Nov; 12(11):2057-2064. PubMed ID: 36053920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.